This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Neurosurgeon Vitor Mendes Pereira, MD, was in Santiago, Panama, but his patient was in Panama City. "It is the highlight of my career to be involved in this historic achievement," Pereira said.
A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.
The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities.
U.S. healthcare will know it’s gotten AI right when the technology demonstrably improves care access, attentiveness and outcomes for the least financially healthy among us.
Already approved for temperature management, the single-use ensoETM device is now cleared for another use: minimizing the risk of potentially fatal injuries to the patient's esophagus during radiofrequency ablation procedures.
Nearly 8 in 10 physicians might balk before seeking mental healthcare due to perceptions of stigma around doctors admitting they need that kind of help.
Hospitals will soon have an opportunity to get their climate-conservation efforts formally recognized by U.S. healthcare’s largest body for setting standards and awarding accreditations.
Physician groups mulling buyout offers from private equity firms often simultaneously entertain alignment opportunities with healthcare systems, including not-for-profits. For this reason, hospitals do well to stay competitive for finite clinical talent.
Almost 80% of provider organizations spent more on IT systems and software this year than last, yet only 6% have a plan in hand to incorporate generative AI into their digital ecosystem.
The ACC has joined forces with Amgen and Esperion Therapeutics to increase LDL screening in patients with and without a history of cardiovascular issues.